EP Patent

EP2253716A1 — Diagnostic methods for the prognosis of a brain tumor

Assigned to Deutsches Krebsforschungszentrum DKFZ · Expires 2010-11-24 · 15y expired

What this patent protects

Described is a diagnostic method for the estimation of a prognosis for patients having a brain tumor using the presence/absence of a particular IDH1 mutation as a prognostic marker, preferably the mutation R132H.

USPTO Abstract

Described is a diagnostic method for the estimation of a prognosis for patients having a brain tumor using the presence/absence of a particular IDH1 mutation as a prognostic marker, preferably the mutation R132H.

Drugs covered by this patent

Patent Metadata

Patent number
EP2253716A1
Jurisdiction
EP
Classification
—
Expires
2010-11-24
Drug substance claim
No
Drug product claim
No
Assignee
Deutsches Krebsforschungszentrum DKFZ
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.